Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models

Overview of attention for article published in BMC Medicine, May 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

blogs: 2 blogs

policy: 1 policy source

Citations

dimensions_citation: 38 Dimensions

Readers on

mendeley: 128 Mendeley

Summary Blogs Policy documents Dimensions citations

So far, Altmetric has seen 2 posts from 2 blogs.

References for tonight’s Inside Health

Comments on: blog at New Statesman, 02 Oct 2012

Gardiasil http://www.whatdotheyknow.com/request/mhra_reports_for_gardasil?unfold=1#incoming-260466 http://www.cdc.gov/vaccine…

Evaluating cost effectiveness models of vaccine implementation

BioMed Central, 12 May 2011

Vaccinations, generally considered to be the most effective method for preventing infectious diseases, provide protection in…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.